Market Overview

Benzinga's Top Upgrades

Related CAH
Who Will Feel The Pain From Generic Drug Price Inflation?
#PreMarket Primer: Friday, October 31: BOJ Spooked By Lackluster Growth And Inflation
Related LLY
7 Stocks You Should Be Watching Today
Zosano Pharma and Eli Lilly and Company Enter Into Exclusive Licensing Agreement for Zosano's ZP-PTH Product Candidate
Eli Lilly Bets Big on Diabetes, Cancer Drugs (Fox Business)

Analysts at ISI Group upgraded Cardinal Health (NYSE: CAH) from “hold” to “buy.” Cardinal Health's shares closed at $40.85 yesterday. Cardinal Health's trailing-twelve-month ROE is 17.70%.

Analysts at Goldman Sachs upgraded Eli Lilly & Co (NYSE: LLY) from “sell” to “neutral.” Eli Lilly's shares closed at $50.78 yesterday. Eli Lilly's trailing-twelve-month revenue is $23.40 billion.

Analysts at Citigroup upgraded The Interpublic Group of Companies (NYSE: IPG) from “neutral” to “buy.” Interpublic Group's stock closed at $11.43 yesterday. Interpublic Group's PEG ratio is 1.16.

Analysts at Sterne Agee upgraded Shoe Carnival (NASDAQ: SCVL) from “neutral” to “buy.” Shoe Carnival's shares closed at $22.65 yesterday. Shoe Carnival's trailing-twelve-month operating margin is 5.61%.

Latest Ratings for CAH

DateFirmActionFromTo
Nov 2014BarclaysMaintainsOverweight
Oct 2014CitigroupMaintainsNeutral
Oct 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for CAH
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CAH + IPG)

Around the Web, We're Loving...

Get Benzinga's Newsletters